Opdivo Intravenous infusion 20mg, manufactured by Ono Pharmaceutical, contains Nivolumab (genetical recombination) and is an immune checkpoint inhibitor used to treat various cancers, including melanoma, lung cancer, and renal cell carcinoma. This 20mg 2mL bottle has a YJ code of 4291427A1024.
Opdivo Intravenous infusion 20mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →